A multicenter phase II study of vorinostat in patients (pts) with relapsed or refractory indolent B-cell non-Hodgkin lymphoma (B-NHL) or mantle cell lymphoma (MCL).
Kiyoshi Ando
Research Funding - MSD; MSD Japan
Michinori Ogura
Research Funding - MSD Japan
Tatsuya Suzuki
Research Funding - MSD; MSD Japan
Kenichi Ishizawa
Research Funding - MSD; MSD Japan
Sung Yong Oh
Research Funding - MSD; MSD Japan
Won Seog Kim
Research Funding - MSD Japan
Yoshinobu Tanaka
No relevant relationships to disclose
Takashi Shimamoto
No relevant relationships to disclose
Kensei Tobinai
Consultant or Advisory Role - Advisory Role
Research Funding - MSD Japan